Christoph Zielinski
Prof. Dr. Christoph Zielinski is a respected and well-known medical oncologist and cancer researcher in Austria. He is one of the best cancer specialists in Europe, currently the head of the Central European Cancer Center in Vienna. He is also President of the Central European Cooperative Oncology Group which is conducting clinical trials and major educational activities in 23 countries of Central and Southeastern Europe.
Prof. Zielinski’s recent clinical research activities cover a wide range of cancer therapies, with particular focus on clinical trials, breast and lung cancer research including the development of concepts related to immune-oncology, targeted drugs, and cancer-related thromboembolism. He has published ca. 600 original papers and reviews in peer-review journals and many books.
He is affiliated with many reputable organizations, such as the European Society for Medical Oncology (ESMO), the Polish Society for Clinical Oncology and also member of the Austrian Society for Hematology and Oncology, the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the Chinese Society for Clinical Oncology (CSCO).
-
1on1 with Christoph Zielinski | Jesenná ITAPA 2023
What is the importance of a healthy population? What does better availability of innovations in healthcare bring? How important is to prioritize investments in healthcare and especially improving the situation for cancer patients? How can innovative cancer prevention and care improve outcomes for patients? What can Slovakia learn from other (CEE) countries’ approaches to innovation? What are key elements of an innovative system of care? Using examples from lung cancer, it will be pointed out how healthcare systems better manage increasing numbers of cancer patients. We will discuss prevention, screening, faster time to diagnosis, referrals, and treatment, improved functioning of guideline management and multidisciplinary teams in oncology centers, availability of innovative drugs etc.
